Lanreotide diTFA
Lanreotide diTFA (BIM 23014) is a somatostatin analog used in cancer research, particularly for studying carcinoid syndrome. It demonstrates antitumor properties in vitro and has been evaluated in vivo for its ability to inhibit hormone secretion and tumor growth in neuroendocrine models.
Product Specifications
Field of Research
Pharmacology & Drug Discovery
Molecular Weight
1324.37
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1393420-01 0.02 mg (E-Coli)
Recombinant Erythrobacter litoralis UDP-N-acetylmuramate--L-alanine ligase (murC)
Sign In for Pricing
View Details 
MBS1393420-02 0.02 mg (Yeast)
Recombinant Erythrobacter litoralis UDP-N-acetylmuramate--L-alanine ligase (murC)
Sign In for Pricing
View Details 
MBS1393420-03 0.1 mg (E-Coli)
Recombinant Erythrobacter litoralis UDP-N-acetylmuramate--L-alanine ligase (murC)
Sign In for Pricing
View Details MBS1393420-04 0.1 mg (Yeast)
Recombinant Erythrobacter litoralis UDP-N-acetylmuramate--L-alanine ligase (murC)
Sign In for Pricing
View Details MBS1393420-05 0.02 mg (Baculovirus)
Recombinant Erythrobacter litoralis UDP-N-acetylmuramate--L-alanine ligase (murC)
Sign In for Pricing
View Details MBS1393420-06 0.02 mg (Mammalian-Cell)
Recombinant Erythrobacter litoralis UDP-N-acetylmuramate--L-alanine ligase (murC)
Sign In for Pricing
View Details